Visceral arterial diseases affect the arteries supplying the abdominal organs. They include stenoses, occlusions and arterial wall lesions, with different consequences depending on the vessel and organ involved. In the mesenteric circulation they may impair digestion and intestinal viability; in the renal circulation they may interfere with blood pressure regulation and kidney function. Thus, an apparently identical stenosis on imaging does not have a uniform meaning: it must be considered in relation to the disease mechanism, circulatory reserve and presence of organ injury.
Renal artery stenosis is often identified during the assessment of hypertension or declining kidney function, but it can also be an incidental finding. Chronic mesenteric ischemia typically becomes apparent when the circulation cannot meet the increased demands of digestion, whereas acute mesenteric ischemia may rapidly progress to intestinal necrosis and multiorgan failure. These syndromes require distinct diagnostic and therapeutic pathways, although they share some vascular determinants.
Atherosclerotic lesions become more common with age and cardiovascular risk factors; other forms result from embolism, fibromuscular dysplasia, dissection, inflammation or trauma. Widespread imaging has increased the detection of asymptomatic abnormalities, making it even more important to distinguish an anatomical finding from clinical disease. An isolated mesenteric stenosis may be compensated for, and a hypertensive patient with renal arterial plaque may have several contributing causes of hypertension. The decision to treat should be based on a plausible clinical benefit, rather than merely the technical possibility of reopening a vessel.
The celiac trunk supplies the liver, stomach, spleen and parts of the duodenum and pancreas through its branches and their anatomical variants. The superior mesenteric artery supplies most of the small intestine and the proximal colon; the inferior mesenteric artery contributes to perfusion of the distal colon and upper rectum. Pancreaticoduodenal arcades, mesenteric connections and the marginal arterial circulation link these territories. Anastomoses provide compensation, but their effectiveness varies and may be altered by previous operations or multivessel disease.
During meals, splanchnic blood flow demand increases. Circulation sufficient at rest may become inadequate when secretion, motility and absorption require greater flow. The intestinal mucosa is metabolically active and vulnerable to reduced oxygen delivery; injury may begin before the entire bowel wall becomes necrotic. Chronic and acute ischemia share this problem of oxygen availability, but differ in speed of onset, compensation and potential for recovery.
The renal arteries arise from the aorta and may have accessory branches. The kidneys receive high blood flow, essential for filtration and homeostasis, but reduced perfusion also triggers hormonal responses that can alter blood pressure and salt–water balance. Unilateral stenosis with a functioning contralateral kidney differs from bilateral disease or disease affecting the only functioning kidney. Assessment must include the renal parenchyma, because restoring inflow to a severely damaged kidney does not guarantee functional recovery.
Atherosclerosis frequently affects the ostia and proximal segments of visceral arteries, often in continuity with aortic disease. Lipid retention, inflammation and remodeling produce plaques that may narrow the lumen or become sites of thrombosis. Smoking, hypertension, diabetes, dyslipidemia and kidney disease promote progression. A visceral atherosclerotic lesion also indicates risk in other vascular territories and calls for cardiovascular prevention in addition to local assessment.
Arterial embolism can abruptly interrupt perfusion in a previously well-supplied territory. A cardiac source, such as atrial fibrillation, or an aortic lesion may send embolic material into the superior mesenteric or renal arteries. Injury depends on the site of lodging, the extent of involvement and available collaterals. Thrombosis arising on an existing plaque may instead cause an acute event in an already compromised circulation, sometimes preceded by chronic symptoms apparent only when the history is reconstructed.
Fibromuscular dysplasia is an important non-atherosclerotic cause of renal arterial disease. Isolated dissections, vasculitis and structural wall abnormalities may affect renal or mesenteric arteries in characteristic distributions. Compression of the celiac trunk by the median arcuate ligament is another mechanism, but the imaging finding is often asymptomatic: attributing symptoms to the clinical syndrome requires caution after other causes of abdominal complaints have been considered.
Aneurysmal disease presents a different problem from stenosis, because rupture, thrombosis or embolization may predominate. Visceral artery aneurysms must be distinguished from pseudoaneurysms, in which wall continuity is disrupted and containment depends on surrounding tissues. Location, cause, growth, symptoms and clinical context modify the risk; no single size threshold is appropriate for every artery and every type of lesion.
Nonocclusive mesenteric ischemia develops when low cardiac output and vasoconstriction compromise flow without a primary embolic or thrombotic obstruction. It may occur in critically ill patients and requires correction of the hemodynamic disturbance. Mesenteric venous thrombosis, by contrast, causes ischemia through impaired outflow and has different diagnostic and therapeutic implications. These conditions belong in the differential diagnosis of intestinal ischemia, but must not all be described as visceral arterial occlusions.
In renovascular disease, reduced perfusion pressure may activate the renin–angiotensin–aldosterone system and sustain vasoconstriction and sodium retention. Over time, microvascular abnormalities, inflammation and fibrosis can make parenchymal injury less reversible. The relationship among stenosis, hypertension and renal failure is therefore not purely mechanical. Diabetes, intrinsic kidney disease and diffuse vascular injury may explain why successful reopening of a vessel does not produce the expected improvement.
Chronic mesenteric ischemia may cause pain after meals, voluntary reduction of food intake and weight loss. Patients may change portion sizes and eating habits to avoid discomfort, initially obscuring its relationship to meals. Nausea, diarrhea and less typical symptoms are possible; absence of the full classic presentation does not exclude disease. On the other hand, malignancies, pancreatic disorders and other gastrointestinal diseases can produce a similar picture and must be considered.
In acute mesenteric ischemia, pain may be severe relative to the initial abdominal findings. This feature is useful when present but is not constant: older people, sedated patients and critically ill patients may have muted or nonspecific manifestations. Vomiting, diarrhea, distension or intestinal bleeding may accompany the event. Guarding, rigidity and peritoneal signs raise concern for advanced injury and must not be awaited before investigations begin.
Renal artery stenosis may be suspected in the setting of difficult-to-control hypertension, unexplained deterioration in kidney function, renal size asymmetry or episodes of acute pulmonary edema in an appropriate context. None of these findings alone proves that stenosis is the cause. Renal infarction may present with flank pain, sometimes hematuria and laboratory abnormalities, mimicking colic or infection. Clarifying embolic risk and the time of onset helps guide imaging.
The vascular and medication history should address atrial fibrillation, previous emboli, known atherosclerosis, abdominal operations, aortic procedures and recent treatment changes. In suspected renovascular hypertension, blood pressure measurements, adherence and medications actually taken must be checked before labeling hypertension resistant. In chronic abdominal pain, weight trends, relation to meals and dietary changes are relevant. In acute presentations, the timeline directly affects the possibility of organ salvage.
The physical examination includes hemodynamic status, hydration, abdominal findings, signs of peritoneal irritation, congestion and peripheral perfusion. An abdominal bruit may suggest turbulent flow, but cannot by itself establish the site, severity or clinical responsibility of a stenosis. Cachexia and malnutrition may accompany chronic ischemia, whereas shock and organ dysfunction signal severity in acute disease. The absence of striking signs must not outweigh well-founded clinical suspicion.
CT angiography is central to investigating mesenteric ischemia because it delineates arteries, possible thrombi, collaterals and bowel wall condition, as well as many alternative diagnoses. When acute ischemia is suspected, it should be performed using an appropriate protocol without avoidable delays; routine abdominal CT without adequate vascular assessment may not answer the clinical question. Kidney function is considered, but the risk of contrast must be balanced against failure to recognize potentially fatal intestinal ischemia.
Duplex ultrasonography may be useful for evaluating renal arteries and chronic mesenteric stenoses, especially in experienced hands. Bowel gas, body habitus, depth, insonation angle and anatomical variants can interfere with the examination. Flow velocities must be interpreted using vessel- and context-specific criteria, not as self-sufficient numbers. In acute presentations, ultrasonography must not delay necessary imaging or treatment simply because it is noninvasive.
MR angiography is an alternative in selected situations, taking into account examination time, image quality, contraindications and contrast agent type. Catheter angiography is mainly used when an intervention is planned or decisive uncertainty remains. In renal arterial disease, invasive hemodynamic measurements may help select certain lesions, but do not replace clinical and parenchymal assessment. The imaging technique should be chosen to answer a specific question.
Laboratory tests document kidney function, electrolytes, blood counts, acid–base balance and other indicators of injury or severity. Lactate may rise with hypoperfusion and necrosis, but a normal value does not exclude early mesenteric ischemia and an elevated value does not prove its cause. No single biomarker can replace clinical judgment and imaging. In chronic forms, minimally altered laboratory results likewise do not negate a compatible clinical picture.
Attributing a symptom to a visceral arterial stenosis requires agreement among vascular territory, mechanism and clinical picture. In mesenteric ischemia, the number of involved vessels, collateral network, symptoms and alternative gastrointestinal diagnoses are considered. Single-vessel disease can be significant in some patients but requires particularly careful selection. Endoscopy and other investigations may rule out coexisting conditions; normal endoscopy does not automatically prove or exclude ischemia.
In renal arterial disease, parenchymal viability and functional relevance are evaluated alongside the narrowing. Kidney size, changes in filtration, proteinuria and blood pressure pattern help establish whether revascularization may still alter the clinical course. Identifying fibromuscular dysplasia or systemic disease may require investigation of other vascular territories. An embolic source should be sought when suggested by the type of occlusion, to prevent further events outside the abdomen as well.
Before treatment, nutritional status, frailty and urgency must be established. In severe chronic ischemia, malnutrition increases risk, but prolonging attempts at nutritional rehabilitation without correcting inadequate perfusion may be counterproductive. In acute disease, the priority is to determine whether nonviable bowel, peritonitis or instability is present. These factors and the availability of a team capable of prompt intervention guide the choice of endovascular, surgical or combined approaches.
Cardiovascular prevention is necessary in atherosclerotic disease and includes smoking cessation, lipid, blood pressure and metabolic control, and antithrombotic agents when indicated. The regimen is tailored to mechanism, procedures and bleeding risk. An embolism from atrial fibrillation calls for a different approach from a stable plaque or isolated dissection. Not all visceral arterial diseases benefit from the same drug combination.
Mesenteric revascularization aims to restore adequate blood supply when clinically significant ischemia is present. In chronic disease, endovascular or surgical approaches are selected according to anatomy, risk and durability. In acute ischemia, stabilization, treatment of the cause and assessment of bowel viability are combined; necrotic bowel requires surgical management. Reopening the artery and appropriately preserving or resecting tissue are complementary objectives. Antibiotics, intensive support and repeated reassessments may be needed in severe cases.
For atherosclerotic renal artery stenosis, randomized trials, including CORAL, do not support routine stenting added to medical therapy in the overall population studied. Selected high-risk situations, such as recurrent pulmonary edema in a convincing renovascular setting or rapid deterioration with salvageable renal parenchyma, may warrant individual assessment. Resistant hypertension must be genuinely documented. Decisions should avoid both intervening on every stenosis and denying any possible individual indication.
In renal fibromuscular dysplasia, angioplasty may have a different role than in atherosclerosis, and stenting is not necessarily part of routine treatment. Uncomplicated visceral dissections may sometimes be managed conservatively, whereas persistent ischemia, rupture or clinically relevant progression changes the strategy. Aneurysms and pseudoaneurysms require their own criteria, based in part on site and cause. Treatment must therefore follow the etiological diagnosis rather than the appearance of an irregular lumen alone.
Antihypertensive therapy in patients with renal arterial disease is titrated while monitoring kidney function and electrolytes. Drugs acting on the renin–angiotensin system require particular caution when perfusion of the entire functioning renal mass is compromised. An increase in creatinine after changing treatment must be interpreted alongside hydration status, diuretics and other causes; it does not automatically demonstrate bilateral stenosis. Monitoring helps maintain effective therapy while avoiding unrecognized deterioration.
Prognosis depends on reversibility of organ injury, timely treatment and comorbidities. In acute intestinal ischemia, delay may turn a potentially reversible perfusion deficit into necrosis; in chronic disease, outcomes include pain relief, resumption of eating and weight recovery. In renal disease, blood pressure control and preservation of function are outcomes distinct from vessel patency. Assessment should measure what the intervention or medication has actually improved.
Follow-up considers recurrence of symptoms, changes in kidney function, nutrition, blood pressure and possible restenosis after treatment. Tests are selected according to the vascular territory and the likelihood that results will change a decision. Aneurysm surveillance instead follows size and specific characteristics. For incidental lesions, the intensity of monitoring and need for further investigations should be proportional to risk; education about new symptoms remains useful even when no procedure is planned.
Intestinal necrosis may lead to perforation, peritonitis, sepsis and multiorgan failure. Extensive resections can leave short bowel syndrome requiring prolonged nutritional support. Even after blood flow is restored, reperfusion and mucosal barrier injury can sustain a major systemic response. Stabilizing the artery therefore does not end management during the first hours and ensuing days.
Renal complications include infarction, parenchymal loss and kidney failure, potentially requiring renal replacement therapy in the most severe cases. Salt and water retention may aggravate congestion and pulmonary edema, while persistent hypertension causes further cardiovascular injury. Aneurysmal lesions and pseudoaneurysms may rupture and cause internal bleeding. The type of complication must be recognized rapidly because hemorrhage, ischemia and volume overload require different interventions.
Treatments may be complicated by thrombosis, embolization, bleeding or restenosis. Procedures involving the aorta and visceral arteries can also dislodge atheromatous material; contrast agents require caution in vulnerable patients, and antithrombotic therapy increases bleeding risk. Prevention combines appropriate indication selection, sound technique and monitoring of target organs. New or rapidly worsening abdominal pain, sudden oliguria, syncope or instability after a procedure calls for prompt reassessment.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.